nitrous oxide has been researched along with Coronary Artery Disease in 7 studies
Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nitrous oxide did not increase the risk of death and cardiovascular complications or surgical-site infection, the emetogenic effect of nitrous oxide can be controlled with antiemetic prophylaxis, and a desired effect of reduced volatile agent use was shown." | 2.79 | The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. ( Beattie, WS; Chan, MT; Devereaux, PJ; Forbes, A; Leslie, K; Myles, PS; Paech, MJ; Peyton, PJ; Schricker, T; Sessler, DI; Silbert, B; Wallace, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bär, S | 1 |
| Praz, F | 1 |
| Räber, L | 1 |
| Fluegge, K | 2 |
| Tramèr, MR | 1 |
| Myles, PS | 2 |
| Leslie, K | 2 |
| Chan, MT | 2 |
| Forbes, A | 1 |
| Peyton, PJ | 1 |
| Paech, MJ | 1 |
| Beattie, WS | 1 |
| Sessler, DI | 1 |
| Devereaux, PJ | 1 |
| Silbert, B | 1 |
| Schricker, T | 1 |
| Wallace, S | 1 |
| Razavi, C | 1 |
| Saha, S | 1 |
| Bo, L | 1 |
| Li, J | 1 |
| Peyton, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Antidepressant Effects of Nitrous Oxide in People With Major Depressive Disorder[NCT05357040] | Phase 2 | 172 participants (Anticipated) | Interventional | 2021-06-30 | Recruiting | ||
| Large, Randomised, Parallel-group, Controlled Trial, With Patients Randomly Allocated to Either N2O-containing (70% N2O in Oxygen [FiO2 0.3]) or N2O-free (70% Nitrogen in Oxygen [FiO2 0.3]).[NCT00430989] | Phase 4 | 7,112 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00430989)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Nitrous Oxide: 70% N2O (FiO2 0.3) | 15 |
| N2O Free Group (FiO2 0.3) | 19 |
(NCT00430989)
Timeframe: 30 Days Post Op
| Intervention | Days (Median) |
|---|---|
| Nitrous Oxide: 70% N2O (FiO2 0.3) | 6.1 |
| N2O Free Group (FiO2 0.3) | 6.1 |
(NCT00430989)
Timeframe: 30 days post op
| Intervention | participants (Number) |
|---|---|
| Nitrous Oxide: 70% N2O (FiO2 0.3) | 215 |
| N2O Free Group (FiO2 0.3) | 219 |
(NCT00430989)
Timeframe: 30 Days Post op
| Intervention | participants (Number) |
|---|---|
| N2O Group (FiO2 0.3) | 18 |
| N2O Free Group (FiO2 0.3) | 22 |
(NCT00430989)
Timeframe: 30 Days Post op
| Intervention | participants (Number) |
|---|---|
| Nitrous Oxide: 70% N2O (FiO2 0.3) | 26 |
| N2O Free Group (FiO2 0.3) | 19 |
(NCT00430989)
Timeframe: 30 days post op
| Intervention | participants (Number) |
|---|---|
| Nitrous Oxide: 70% N2O (FiO2 0.3) | 283 |
| N2O Free Group (FiO2 0.3) | 296 |
(NCT00430989)
Timeframe: 30 Days Post op
| Intervention | participants (Number) |
|---|---|
| Nitrous Oxide: 70% N2O (FiO2 0.3) | 321 |
| N2O Free Group (FiO2 0.3) | 311 |
1 trial available for nitrous oxide and Coronary Artery Disease
| Article | Year |
|---|---|
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.
Topics: Aged; Anesthesia, General; Anesthetics, Combined; Anesthetics, Inhalation; Cardiovascular Diseases; | 2014 |
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.
Topics: Aged; Anesthesia, General; Anesthetics, Combined; Anesthetics, Inhalation; Cardiovascular Diseases; | 2014 |
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.
Topics: Aged; Anesthesia, General; Anesthetics, Combined; Anesthetics, Inhalation; Cardiovascular Diseases; | 2014 |
The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial.
Topics: Aged; Anesthesia, General; Anesthetics, Combined; Anesthetics, Inhalation; Cardiovascular Diseases; | 2014 |
6 other studies available for nitrous oxide and Coronary Artery Disease
| Article | Year |
|---|---|
Plaque erosion causing ST-elevation myocardial infarction after consumption of cannabis and N
Topics: Administration, Inhalation; Adult; Anesthetics, Inhalation; Angioplasty, Balloon, Coronary; Coronary | 2021 |
Environmental factors influencing the link between childhood ADHD and risk of adult coronary artery disease.
Topics: Adult; Air Pollutants; Apelin; Attention Deficit Disorder with Hyperactivity; Child; Coronary Artery | 2018 |
Do we need to know whether nitrous oxide harms patients?
Topics: Anesthesia, General; Anesthetics, Inhalation; Coronary Artery Disease; Female; Humans; Male; Nitrous | 2014 |
Nitrous oxide in general anaesthesia.
Topics: Anesthesia, General; Anesthetics, Inhalation; Coronary Artery Disease; Female; Humans; Male; Nitrous | 2015 |
Nitrous oxide in general anaesthesia.
Topics: Anesthesia, General; Anesthetics, Inhalation; Coronary Artery Disease; Female; Humans; Male; Nitrous | 2015 |
Nitrous oxide in general anaesthesia - Authors' reply.
Topics: Anesthesia, General; Anesthetics, Inhalation; Coronary Artery Disease; Female; Humans; Male; Nitrous | 2015 |